These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11209286)

  • 41. Psychotic symptoms in Parkinson's disease: pathophysiology and management.
    Bosboom JL; Wolters ECh
    Expert Opin Drug Saf; 2004 May; 3(3):209-20. PubMed ID: 15155149
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [General practice study with atypical neuroleptics. Differences in tolerance].
    MMW Fortschr Med; 2002 May; Suppl 2():86. PubMed ID: 12070866
    [No Abstract]   [Full Text] [Related]  

  • 43. Weight change in Parkinson and Alzheimer patients taking atypical antipsychotic drugs.
    Sitburana O; Rountree S; Ondo WG
    J Neurol Sci; 2008 Sep; 272(1-2):77-82. PubMed ID: 18556024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of psychotic complications of Parkinson disease with clozapine].
    Ozsancak C; Auzou P; Ronzière T; Hannequin D; Augustin P
    Presse Med; 1997 Nov; 26(33):1599-602. PubMed ID: 9452762
    [No Abstract]   [Full Text] [Related]  

  • 45. Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias.
    Aarsland D; Perry R; Larsen JP; McKeith IG; O'Brien JT; Perry EK; Burn D; Ballard CG
    J Clin Psychiatry; 2005 May; 66(5):633-7. PubMed ID: 15889951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quetiapine as treatment for dopaminergic-induced dyskinesias in Parkinson's disease.
    Baron MS; Dalton WB
    Mov Disord; 2003 Oct; 18(10):1208-9. PubMed ID: 14534933
    [No Abstract]   [Full Text] [Related]  

  • 47. Seizures associated with quetiapine treatment.
    Dogu O; Sevim S; Kaleagasi HS
    Ann Pharmacother; 2003 Sep; 37(9):1224-7. PubMed ID: 12921503
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quetiapine-induced hypothyroidism.
    Ramaswamy S; Siddiqui Z; Saharan S; Gabel TL; Bhatia SC
    J Psychiatry Neurosci; 2005 Jan; 30(1):57. PubMed ID: 15645000
    [No Abstract]   [Full Text] [Related]  

  • 49. Underlying mechanisms of psychosis and aggression in patients with Alzheimer's disease.
    Mintzer JE
    J Clin Psychiatry; 2001; 62 Suppl 21():23-5. PubMed ID: 11584984
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuroleptic malignant syndrome with use of quetiapine in mental retardation.
    Dan A; Bharadwaj R; Grover S
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):255-6. PubMed ID: 19335404
    [No Abstract]   [Full Text] [Related]  

  • 51. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
    Meco G; Bernardi S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Challenges in the management of psychotic symptoms in long-term care.
    Gravenstein S; Beier M; Singer C
    J Am Med Dir Assoc; 2003; 4(4 Suppl):H17-20. PubMed ID: 12857363
    [No Abstract]   [Full Text] [Related]  

  • 53. Treatment of Psychosis in Parkinson's disease and sudden death.
    Kyle K; Bronstein JM
    Parkinsonism Relat Disord; 2020 Oct; 79():127. PubMed ID: 32943345
    [No Abstract]   [Full Text] [Related]  

  • 54. A New Hope in Alzheimer's Disease Psychosis: Pimavanserin.
    Kurhan F; Akın M
    Curr Alzheimer Res; 2023; 20(6):403-408. PubMed ID: 37641988
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pimavanserin for Parkinson Disease Psychosis.
    Mohanty D; Sarai S; Naik S; Lippmann S
    Prim Care Companion CNS Disord; 2019 Apr; 21(2):. PubMed ID: 31050230
    [No Abstract]   [Full Text] [Related]  

  • 56. 5-HT
    Huot P
    Neurodegener Dis Manag; 2018 Dec; 8(6):363-365. PubMed ID: 30451579
    [No Abstract]   [Full Text] [Related]  

  • 57. Difficult choices in treating Parkinson's disease psychosis.
    The Lancet Neurology
    Lancet Neurol; 2018 Jul; 17(7):569. PubMed ID: 29858161
    [No Abstract]   [Full Text] [Related]  

  • 58. Quetiapine for Parkinson's Disease psychosis: Evidence-based medicine versus expert belief: A case study.
    Friedman JH
    Mov Disord; 2018 Jul; 33(7):1186-1187. PubMed ID: 29644756
    [No Abstract]   [Full Text] [Related]  

  • 59. 5-HT
    Kwan C; Huot P
    Neurodegener Dis Manag; 2019 Oct; 9(5):251-253. PubMed ID: 31580227
    [No Abstract]   [Full Text] [Related]  

  • 60. Successful Use of Brexpiprazole for Parkinson's Disease Psychosis Without Adverse Effects: A Case Report.
    Sanagawa A; Shiraishi N; Sekiguchi F; Akechi T; Kimura K
    J Clin Psychopharmacol; 2019; 39(6):685-687. PubMed ID: 31688389
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.